Neuropsychological, neuroanatomical, and neurophysiological consequences of CNS chemotherapy for acute lymphoblastic leukemia

Archives of Clinical Neuropsychology

Volumn 15, Issue 7, 2000, Pages 603-630

  Moleski, Maria ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYTARABINE; HYDROCORTISONE; METHOTREXATE;

ACADEMIC ACHIEVEMENT; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BRAIN ATROPHY; BRAIN METABOLISM; CANCER CHEMOTHERAPY; COGNITION; EVOKED RESPONSE; HUMAN; INTELLIGENCE TEST; MICROANGIOPATHY; NEUROANATOMY; NEUROPHYSIOLOGY; NEUROPSYCHOLOGY; RADIATION RESPONSE; SENSORIMOTOR FUNCTION; SURVIVAL RATE; WHITE MATTER;

EID: 0033797954     PISSN: 08876177     EISSN: 18735843     Source Type: Journal    
DOI: 10.1016/S0887-6177(99)00050-5     Document Type: Article

References (133)

1. Allen J.C. The effects of cancer therapy on the nervous system. Journal of Pediatrics. 93:1978;903-909.
2. Anderson V., Smibert E., Ekert H., Godber T. Intellectual, educational, and behavioral sequelae after cranial irradiation and chemotherapy. Archives of Disease in Childhood. 70:1994;476-485.
3. Baron I.S., Fennell E.B., Voeller K.K. Pediatric neuropsychology in the medical setting. 1995;Oxford University Press, New York.
4. Bender B.G., Lerner J.A., Kollash E. Mood and memory changes in asthmatic children receiving corticosteroids. Journal of the American Academy of Child and Adolescent Psychiatry. 27:1988;720-725.
5. Berg R.A., Ch'ien L.T., Bowman W.P., Ochs J., Lancaster W., Goff J.R., Anderson H.R. The neuropsychological effects of acute lymphocytic leukemia and its treatment - A three-year report. Intellectual functioning and academic achievement Clinical Neuropsychology. 5:1983;9-13.
6. Berg S., Poplack D.G. Clinical manifestations of acute lymphocytic leukemia in children. Hoffman R., Benz E.J., Shattil S.J., Furie B., Cohen H.J., Silberstein L.E. Hematology, basic principles and practice. 2nd ed:1995;1067-1074 Churchill Livingstone, New York.
7. Biti G.P., Magrini S.M., Villari N., Caramella D., Guazzelli G., Rosi A., Liffi A. Brain damage after treatment for acute lymphoblastic leukemia. A report on 34 patients with special regard to MRI findings Acta Oncologica. 28:1989;253-256.
8. Bleyer W.A. Methotrexate. Clinical pharmacology, current status and therapeutic guidelines Cancer Treatment Review. 4:1977;87-101.
9. Bleyer W.A. Central nervous system leukemia. Pediatric Clinics of North America. 35:1988;789-814.
10. Bleyer W.A., Fallavollita J., Robison L., Balsom W., Meadows A., Heyn R., Sitarz A., Ortega J., Miller D., Constine L., Nesbit M., Sather H., Hammond D. Influence of age, sex, and concurrent intrathecal methotrexate therapy on intellectual function after cranial irradiation during childhood. A report from the Children's Cancer Study Group Pediatric Hematology & Oncology. 7:1990;329-338.
11. Bleyer W.A., Poplack D.G. Prophylaxis and treatment of leukemia in the central nervous system and other sanctuaries. Seminars in Oncology. 12:1985;131-148.
12. Boon D.L., Murdoch B.E., Jordan F.M. Performance on creative narrative tasks of children treated for acute lymphocytic leukemia. Aphasiology. 8:1994;549-568.
13. Brouwers P. Neuropsychological abilities of long-term survivors of childhood leukemia. Aaronson N.K., Beckmann J. The quality of life of cancer patients. 1987;153-165 Raven Press, New York.
14. Brouwers P., Moss H., Reaman G.H. Central nervous system preventive therapy with systemic high dose methotrexate versus cranial radiation and intrathecal methotrexate. Comparison of effects of treatment on academic achievement in children with acute lymphoblastic leukemia Proceedings American Society of Clinical Oncology. 7:1988;176.
15. Brouwers P., Riccardi R., Poplack D., Fedio R. Attentional deficits in long-term survivors of childhood acute lymphoblastic leukemia (ALL). Journal of Clinical Neuropsychology. 6:1984;325-336.
16. Brown R.R., Sawyer M.B., Antoniou G., Toogood I., Rice M., Thompson N., Madan-Swain A. A 3-year follow-up of the intellectual and academic functioning of children receiving central nervous system prophylactic chemotherapy for leukemia. Journal of Developmental & Behavioral Pediatrics. 17:1996;392-398.
17. Brown R.T., Madan-Swain A., Pais R., Lambert R.G., Baldwin K., Casey R., Frank N., Sexson S.B., Ragab A. Cognitive status of children treated with central nervous system prophylactic chemotherapy for acute lymphocytic leukemia. Archives of Clinical Neuropsychology. 7:1992;481-497.
18. Butler R.W., Hill J.M., Steinherz P.G., Meyers P.A., Finlay J.L. Neuropsychologic effects of cranial irradiation, intrathecal methotrexate, and systemic methotrexate in childhood cancer. Journal of Clinical Oncology. 12:1994;2621-2629.
19. Chiappa K.H. Evoked Potentials in Clinical Medicine. 2nd ed:1990;Raven Press, New York.
20. Clarke R., Daly L., Robinson K., Naughten E., Cahalane S., Fowler B., Graham I. Hyperhomocysteinemia. An independent risk factor for vascular disease New England Journal of Medicine. 51:1991;828-835.
21. Colamaria V., Caraballo R., Borgna-Pignatti C., Marradi P., Balter R., Mazza C., Procacci C., Bernadina B.D. Transient focal leukoencephalopathy following intraventricular methotrexate and cytarabine. Child's Nervous System. 6:1990;231-235.
22. Copeland D.R. Neuropsychological and psychosocial effects of childhood leukemia and its treatment. CA - A Cancer Journal for Clinicians. 42:1992;283-295.
23. Copeland D.R., Dowell R.E., Fletcher J.M., Bordeaux D., Sullivan M.P., Jaffe N., Frankel L.S., Ried H.L., Cangir A. Neuropsychological effects of childhood cancer treatment. Journal of Child Neurology. 3:1988;53-62. a.
24. Copeland D.R., Dowell R.E., Fletcher J.M., Sullivan M.P., Jaffe N., Cangir A., Frankel L., Judd B.W. Neuropsychological test performance of pediatric cancer patients at diagnosis and one year later. Journal of Pediatric Psychology. 13:1988;183-196. b.
25. Copeland D.R., Moore B.D., Francis D.J., Jaffe N., Culbert S.J. Neuropsychologic effects of chemotherapy on children with cancer - A longitudinal study. Journal of Clinical Oncology. 14:1996;2826-2835.
26. Cousens P., Ungerer J.A., Crawford J.A., Stevens M. Cognitive effects of childhood leukemia therapy. A case for four specific deficits Journal of Pediatric Psychology. 16:1991;475-488.
27. Cousens P., Waters B., Said J., Stevens M. Cognitive effects of cranial irradiation in leukemia. A survey and meta-analysis Journal of Child Psychology & Psychiatry & Allied Disciplines. 29:1988;839-852.
28. Crosley C.J., Rorke L.B., Evans A., Nigro M. Central nervous system lesions in childhood leukemia. Neurology. 28:1978;678-685.
29. Dowell R.E., Copeland D.R., Francis D.J., Fletcher J.M., Stovall M. Absence of synergistic effects of CNS treatments on neuropsychologic test performance among children. Journal of Clinical Oncology. 9:1991;1029-1036.
30. Dowell R.E., Copeland D.R., Judd B.W. Neuropsychological effects of chemotherapeutic agents. Developmental Neuropsychology. 5:1989;17-24.
31. Eden O.B. Central nervous system-directed therapy in acute lymphoblastic leukemia. Pediatric Hematology & Oncology. 12:1995;525-530.
32. Eiser C. Cognitive deficits in children treated for leukemia. Last B.F., van Veldhuizen A.M. Developments in pediatric psychosocial oncology. 1992;69-78 Swets & Zeitlinger, Amsterdam.
33. Esseltine D.W., Freeman C.R., Chevaller L.M., Smith R., O'Gorman A.M., Dube J., Whitehead V.M., Nogrady M.B. Computed tomography brain scans in long term survivors of childhood acute lymphoblastic leukemia. Medical and Pediatric Oncology. 9:1981;429-438.
34. Fletcher J.M., Copeland D.R. Neurobehavioral effects of central nervous system prophylactic treatment of cancer in children. Journal of Clinical and Experimental Neuropsychology. 10:1988;495-538.
35. Garcia-Tena J., Lopez-Andreu J.A., Ferris J., Menor F., Mulas F., Millet E., Verdeguer A. Intrathecal chemotherapy-related myeloencephalopathy in a young child with acute lymphoblastic leukemia. Pediatric Hematology & Oncology. 12:1995;377-385.
36. Giralt J., Ortega J.J., Olive T., Verges R., Forio I., Salvador L. Long-term neuropsychologic sequelae of childhood leukemia. Comparison of two CNS prophylactic regimens International Journal of Radiation Oncology/Biology/Physics. 24:1992;49-53.
37. Glauser T.A., Packer R.J. Cognitive deficits in long-term survivors of childhood brain tumors. Child's Nervous System. 7:1991;2-12.
38. Goff J.R., Anderson H.R., Cooper P.F. Distractibility and memory deficits in long-term survivors of acute lymphoblastic leukemia. Developmental and Behavioral Pediatrics. 1:1980;158-163.
39. Halberg F.E., Kramer J.H., Moore I.M., Wara W.M., Matthay K.K., Ablin A.R. Prophylactic cranial irradiation dose effects on late cognitive function in children treated for acute lymphoblastic leukemia. International Journal of Radiation Oncology/Biology/Physics. 22:1991;13-16.
40. Harila-Saari A.H., Ahonen A.K., Vainionpaa L.K., Paakko E.L., Pyhtinen J., Himanen A.S., Torniainen P.J., Lanning B.M. Brain perfusion after treatment of childhood acute lymphoblastic leukemia. Journal of Nuclear Medicine. 38:1997;82-88.
41. Hertzberg H., Huk W.J., Ueberall M.A., Langer T., Meier W., Dopfer R., Skalej M., Lackner H., Bode U., Janssen G., Zintl F., Beck J.D. CNS late effects after ALL therapy in childhood. 1. Neuroradiological findings in long-term survivors of childhood ALL - An evaluation of the interferences between morphology and neuropsychological performance. Medical & Pediatric Oncology. 28:1997;387-400.
42. Heukrodt C., Powazek M., Brown W.S., Kennelly D., Imbus C., Robinson H., Schantz S. Electrophysiological signs of neurocognitive deficits in long-term leukemia survivors. Journal of Pediatric Psychology. 13:1988;223-236.
43. Hongwei Q., Jianjun F., Yonghong Z., Yamei H., Xinmin Z. Intelligence function in children with acute lymphoblastic leukemia after treatment. Chinese Medical Sciences Journal. 8:1993;91-94.
44. Huang L.T., Hsiao C.C., Weng H.H., Lui C.C. Neurologic complications of pediatric systemic malignancies. Journal of the Formosan Medical Association. 95:1996;209-212.
45. Ivnik R.J., Colligan R.C., Obetz S.W., Smithson W.A. Neuropsychological performance among children in remission from acute lymphocytic leukemia. Journal of Developmental and Behavioral Pediatrics. 2:1981;29-34.
46. Jaffe N., Takaue Y., Anzai T., Robertson R. Transient neurologic disturbances induced by high-dose methotrexate treatment. Cancer. 56:1985;1356-1360.
47. Jankovic M., Brouwers P., Valsecchi M.G., Van Veldhulzen A., Hulsman J., Kamphuis R., Kingma A., Mor W., Van Dongen-Melman J., Ferronato L., Mancini M.A., Spinetta J.J., Masera G. Association of 1800 cGy cranial irradiation with intellectual function in children with acute lymphoblastic leukemia. Lancet. 344:1994;224-227.
48. Jannoun L. Are cognitive and educational development affected by age at which prophylactic therapy is given in acute lymphoblastic leukemia? Archives of Disease in Childhood. 58:1983;953-958.
49. Jannoun L., Chessells J.M. Long-term psychological effects of childhood leukemia and its treatment. Pediatric Hematology and Oncology. 4:1987;293-308.
50. Jordan F.M., Murdoch B.E., Buttsworth D.L., Hudson-Tennent L.J. Speech and language performance of brain-injured children. Aphasiology. 9:1995;23-32.
51. Kato M., Azuma E., Ido M., Ito M., Nii R., Higuchi K., Ihara T., Kamiya H., Sakurai M. Ten-year survey of the intellectual deficits in children with acute lymphoblastic leukemia receiving chemoimmunotherapy. Medical & Pediatric Oncology. 21:1993;435-440.
52. Kingma A., Mooyaart E.L., Kamps W.A., Nieuwenhuizen P., Wilmink J.T. Magnetic resonance imaging of the brain and neuropsychological evaluation in children treated for acute lymphoblastic leukemia at a young age. The American Journal of Pediatric Hematology/Oncology. 15:1993;231-238.
53. Kleinman S.N., Waber D.P. Prose memory strategies of children treated for leukemia. A story grammar analysis of the Anna Thompson passage Neuropsychology. 8:1994;464-470.
54. Komatsu K., Takada G., Uemura K., Shishido F., Kanno I. Decrease in cerebral metabolic rate of glucose after high-dose methotrexate in childhood acute lymphocytic leukemia. Pediatric Neurology. 6:1990;303-306.
55. Kun L.E., Mulhern R.K., Crisco J.J. Quality of life in children treated for brain tumors. Intellectual, emotional and academic function Journal of Neurosurgery. 58:1983;1-6.
56. Lansky S.B., Cairns N.U., Zwarjies W. School attendance among children with cancer. A report from two centres Journal of Psychosocial Oncology. 1:1983;75-82.
57. Lansky S.B., Cairns N.U., Zwarjies W. Central nervous system prophylaxis. Studies showing impairment in verbal skills and academic achievement American Journal of Pediatric Hematology and Oncology. 6:1984;183-190.
58. Lipton S.A., Rosenberg P.A. Mechanisms of disease. Excitatory amino acids as a final common pathway for neurologic disorders New England Journal of Medicine. 330:1994;613-622.
59. Liu H.C., Liang D.C., Chen S.H., Lo C.Y., Tseng K.P., Kuo T.B., Chen H.J., Wang S.J. Intelligence quotient in childhood acute lymphoblastic leukemia after prophylactic treatment in central nervous system with 18 Gy cranial irradiation and intrathecal methotrexate. Acta Paediatrica Sinica. 37:1996;107-110.
60. Lovblad K.O., Kelkar P., Ozdoba C., Ramelli G., Remonda L., Schroth G. Pure methotrexate encephalopathy presenting with seizures. CT and MRI features Pediatric Radiology. 28:1998;86-91.
61. MacLean W.E., Noll R.B., Stehbens J.A., Kaleita T.A., Schwartz E., Whitt J.K., Cantor N.L., Waskerwitz M., Ruymann F., Novak L.J., Woodard A., Hammond G.D. Neuropsychological effects of cranial irradiation in young children with acute lymphoblastic leukemia 9 months after diagnosis. Archives of Neurology. 52:1995;156-160.
62. Madan-Swain A., Brown R.T. Cognitive and psychosocial sequelae for children with acute lymphocytic leukemia and their families. Clinical Psychology Review. 11:1991;267-294.
63. Majovski J. Higher cortical functions in children. Reynolds C.R., Fletcher-Janzen E. Handbook of child neuropsychology. 1989;41-67 Plenum Press, New York.
64. Maria B.L., Dennis M., Obonsawin M. Severe permanent encephalopathy in acute lymphoblastic leukemia. Canadian Journal of Neurological Sciences. 20:1993;199-205.
65. Maytal J., Grossman R., Yusuf F.H., Shende A.C., Karayalycin G., Lanzkowsky P., Schaul N., Eviatar L. Prognosis and treatment of seizures in children with acute lymphoblastic leukemia. Epilepsia. 36:1995;831-836.
66. McIntosh A., Fischer D.B., Rothman S.G., Rosenfield N., Lobel J.S., O'Brien R.T. Intracranial calcifications in childhood leukemia. Journal of Pediatrics. 91:1977;909-913.
67. McKenna S.M., Baehner R.L. Diagnosis and treatment of childhood acute lymphocytic leukemia. Wiernik P.H., Canellos G.P., Kyle R.A., Schiffer C.A. Neoplastic diseases of the blood. 1991;231-251 Churchill Livingstone, New York.
68. Meadows A.T., Massari D.J., Fergusson J., Gordon J., Littman P., Moss K. Declines in IQ scores and cognitive dysfunctions in children with acute lymphocytic leukemia treated with cranial irradiation. Lancet. 2:1981;1015-1018.
69. Mizusawa S., Kondoh Y., Murakami M., Nakamichi H., Sasaki H., Komatsu K., Takahashi A., Kudoh Y., Watanabe K., Ono Y., Uemura K. Effect of methotrexate on local cerebral blood flow in conscious rats. Japanese Journal of Pharmacology. 48:1988;499-501.
70. Moehle K.A., Berg R.A. Academic achievement and intelligence test performance in children with cancer at diagnosis and one year later. Journal of Developmental & Behavioral Pediatrics. 6:1985;62-64.
71. Moore B.D., Copeland D.R., Ried H., Levy B. Neurophysiological basis of cognitive deficits in long-term survivors of childhood cancer. Archives of Neurology. 49:1992;809-817.
72. Moore, I. M., Espy, K. A., Kaufmann, P. M., Kramer, J., Kaemingk, K., Miketova, P., Mollova, N., Kramer, R., Kaspar, M., Pasvogel, A., Schram, K., Wara, W., Hutter, J., & Matthay, K. (2000). Cerebral spinal fluid phospholipids, intellectual and academic abilities in children receiving central nervous system treatment. Manuscript submitted for publication.
73. Moss H.A., Nannis E.D., Poplack D.G. The effects of prophylactic treatment of the central nervous system on the intellectual functioning of children with acute lymphocytic leukemia. American Journal of Medicine. 71:1981;47-52.
74. Mulhern R.K. Neuropsychological late effects. Bearison D.J., Mulhern R.K. Pediatric psychooncology. 1994;99-121 Oxford University Press, New York.
75. Mulhern R.K., Fairclough D., Ochs J. A prospective comparison of neuropsychologic performance of children surviving leukemia who received 18-Gy, 24-Gy, or no cranial irradiation. Journal of Clinical Oncology. 9:1991;1348-1356.
76. Mulhern R.K., Kovnar E., Langston J., Carter M., Fairclough D., Leigh L., Kun L.E. Long-term survivors of leukemia treated in infancy. Factors associated with neuropsychologic status Journal of Clinical Oncology. 10:1992;1095-1102.
77. Mulhern R.K., Wasserman A.L., Fairclough D., Ochs J. Memory function in disease-free survivors of childhood acute lymphocytic leukemia given CNS prophylaxis with or without 1,800 cGy cranial irradiation. Journal of Clinical Oncology. 6:1988;315-320.
78. Nesbit M.E., D'Angio G.J., Sather H.N. Effect of isolated CNS leukaemia on bone marrow remission and survival in childhood ALL. Lancet. 1:1981;461-466.
79. Nesbit M.E., Sather H.N., Robison L.L., Ortega J.A., Hammond G.D. A randomized study of 3 years versus 5 years of chemotherapy in childhood lymphoblastic leukemia. Journal of Clinical Oncology. 1:1983;308-316.
80. Ochs J., Bowman W.P., Pui C.H., Ambromowitch M., Mason C., Simone J.V. Seizures in childhood lymphoblastic leukaemia patients. Lancet. 1:1984;793-798.
81. Ochs J., Mulhern R., Fairclough D., Parvey L., Whitaker J., Ch'ien L., Mauer A., Simone J. Comparison of neuropsychologic functioning and clinical indicators of neurotoxicity in long-term survivors of childhood leukemia given cranial radiation or parenteral methotrexate. A prospective study Journal of Clinical Oncology. 9:1991;145-151.
82. Ochs J.J., Parvey L.S., Whitaker J.N., Bowman W.P., Ch'ien L., Cambell M., Coburn T. Serial cranial computed-tomography scans in children with leukemia given two different forms of central nervous system therapy. Journal of Clinical Oncology. 1:1983;793-798.
83. O'Hare A.E., Aitken K., Eden O.B. Computerized psychometry screening in long-term survivors of childhood acute lymphoblastic leukemia. Pediatric Hematology and Oncology. 5:1988;197-208.
84. Osterlundh G., Bjure J., Lannering B., Kjellmer I., Uvebrant P., Marky I. Studies of cerebral blood flow in children with acute lymphoblastic leukemia. Case reports of six children treated with methotrexate examined by single photon emission computed tomography Journal of Pediatric Hematology/Oncology. 19:1997;28-34.
85. Paakko E., Vainionpaa L., Pyhtinen J., Lanning M. Minor changes on cranial MRI during treatment in children with acute lymphoblastic leukemia. Neuroradiology. 38:1996;264-268.
86. Packer R.J., Meadows A.T., Rorke L.B., Goldwein J.L., D'Angio G. Long-term sequelae of cancer treatment on central nervous system in childhood. Medical and Pediatric Oncology. 15:1987;241-253.
87. Pavlovsky S., Fisman N., Arizaga R., Castano J., Chamoles N., Leiguarda R., Moreno R. Neuropsychological study in patients with ALL. Two different CNS prevention therapies - Cranial irradiation plus IT methotrexate vs. IT methotrexate alone. American Journal of Pediatric Hematology and Oncology. 5:1983;79-86.
88. Peckham V. Educational deficits in survivors of childhood cancer. Pediatrician. 18:1991;25-31.
89. Peckham V.C., Meadows A.T., Bartel N., Marrero O. Educational late effects in long-term survivors of childhood acute lymphocytic leukemia. Pediatrics. 81:1988;127-133.
90. Pedersen H., Clausen N. The development of cerebral CT changes during treatment of acute lymphocytic leukemia in childhood. Neuroradiology. 22:1981;79-84.
91. Pfefferbaum-Levine B., Copeland D.R., Fletcher J.M., Ried H., Jaffe N., McKinnon W.R. Neuropsychologic assessment of long-term survivors of childhood leukemia. American Journal of Pediatric Hematology/Oncology. 6:1984;123-128.
92. Phillips P.C., Moeller J.R., Sidtis J.J., Dhawan V., Steinherz P.G., Strother S.C., Ginos J.Z., Rottenberg D.A. Abnormal cerebral glucose metabolism in long-term survivors of childhood acute lymphocytic leukemia. Annals of Neurology. 29:1991;263-271.
93. Picard E.M., Rourke B.P. Neuropsychological consequences of prophylactic treatment for acute lymphocytic leukemia. Rourke B.P. Syndrome of nonverbal learning disabilities. 1995;282-330 Guilford Press, New York.
94. Prassopoulos P., Cavouras D., Golfinopoulos S., Evlogias N., Theodoropoulos V., Panagiotou J. Quantitative assessment of cerebral atrophy during and after treatment in children with acute lymphoblastic leukemia. Investigative Radiology. 31:1996;749-754.
95. Price R.A. Therapy related central nervous system diseases in children with acute lymphoblastic leukaemia. Mastrangelo R., Poplack D.G., Riccardo R. Central nervous system leukemia. 1983;71-82 Martinus Nijhoff, Boston.
96. Price R.A., Jamieson P.A. The central nervous system in childhood leukemia. II. Subacute leukoencephalopathy. Cancer. 35:1975;306-318.
97. Quinn C.T., Griener J.C., Bottiglieri T., Hyland K., Farrow A., Kamen B.A. Elevation of homocysteine and excitatory amino acid neurotransmitters in the CSF of children who receive methotrexate for the treatment of cancer. Journal of Clinical Oncology. 15:1997;2800-2806.
98. Quinn C.T., Griener J.C., Bottiglieri T., Kamen B.A. Methotrexate, homocysteine, and seizures. Journal of Clinical Oncology. 16:1998;393-394. [letter].
99. Robison L.L., Meadows A.T., Nesbit M.E., Ortega J.A., Sather H.N., Hammond G.D. Factors associated with IQ scores in long-term survivors of childhood acute lymphoblastic leukemia. The American Journal of Pediatric Hematology/Oncology. 6:1984;115-121.
100. Robison L.L., Mertens A., Neglia J.P. Epidemiology and etiology of childhood cancer. Fernbach D.J., Vietti T.J. Clinical pediatric oncology. 1991;11-28 Mosby Year Book, St. Louis, MO.
101. Rodgers J., Britton P.G., Morris R.G., Kernahan J., Craft A.W. Memory after treatment for acute lymphoblastic leukemia. Archives of Disease in Childhood. 67:1992;266-268.
102. Rourke B.P. Syndrome of nonverbal learning disabilities. The final common pathway of white-matter disease/dysfunction? Clinical Neuropsychologist. 1:1987;209-234.
103. Rowland J.H., Glidewell O.J., Sibley R.F., Holland J.C., Tull R., Berman A., Brecher M.L., Harris M., Clicksman A.S., Forman E., Jones B., Cohen M.E., Duffner P.K., Freeman A.I. Effects of different forms of central nervous system prophylaxis on neuropsychologic function in childhood leukemia. Journal of Clinical Oncology. 2:1984;1327-1335.
104. Rubenstein C.L., Varni J.W., Katz E.R. Cognitive functioning in long-term survivors of childhood leukemia. A prospective analysis Journal of Developmental & Behavioral Pediatrics. 11:1990;301-305.
105. Rubenstein L.J., Herman M.M., Long T.F., Wilbur J.R. Disseminated necrotizing leukoencephalopathy. A complication of treated central nervous system leukemia and lymphoma Cancer. 35:1975;291-305.
106. Said J.A., Waters B.G.H., Cousens P., Stevens M.M. Neuropsychological sequelae of central nervous system prophylaxis in survivors of childhood acute lymphoblastic leukemia. Journal of Consulting and Clinical Psychology. 57:1989;251-256.
107. Schlieper A.E., Esseltine D.W., Tarshis E. Cognitive function in long survivors of childhood acute lymphoblastic leukemia. Pediatric Hematology and Oncology. 6:1989;1-9.
108. Seidel H., Nygaard R., Haave I., Moe P.J. Magnetic resonance imaging and neurological evaluation after treatment with high-dose methotrexate for acute lymphocytic leukemia in young children. Acta Paediatr. 85:1996;450-453.
109. Shapiro W.R., Chernik N.L., Posner J.B. Necrotizing encephalopathy following intraventricular instillation of methotrexate. Archives of Neurology. 28:1973;96-102.
110. Smibert E., Anderson V., Godber T., Ekert H. Risk factors for intellectual and educational sequelae of cranial irradiation in childhood acute lymphoblastic leukemia. British Journal of Cancer. 73:1996;825-830.
111. Stehbens J.A., Kaleita T.A., Noll R.B., MacLean W.E., O'Brien R.T., Waskerwitz M.J., Hammond G.D. CNS prophylaxis of childhood leukemia. What are the long-term neurological, neuropsychological, and behavioral effects? Neuropsychology Review. 2:1991;147-177.
112. Stehbens J.A., MacLean W.E., Kaleita T.A., Noll R.B., Schwartz E., Cantor N.L., Woodard A., Whitt J.K., Waskerwitz M.J., Ruymann F.B., Hammond G.D. Effects of CNS prophylaxis on the neuropsychological performance of children with acute lymphoblastic leukemia. Nine months postdiagnosis Children's Health Care. 23:1994;231-250.
113. Suzuki K., Takemura T., Okeda R., Hatakeyama S. Vascular changes of methotrexate-related disseminated necrotizing leukoencephalopathy. Acta Neuropathologica. 65:1984;145-149.
114. Tamaroff M., Miller D.R., Murphy M.L., Salwen R., Ghavimi F., Nir Y. Immediate and long-term posttherapy neuropsychologic performance in children with acute lymphoblastic leukemia treated without central nervous system radiation. Journal of Pediatrics. 101:1982;524-529.
115. Taylor H.G., Albo V.C., Phebus C., Sachs B.R., Birl P.G. Post irradiation treatment outcomes for children with acute lymphocytic leukemia. Journal of Pediatric Psychology. 12:1987;394-411.
116. Trautman P.D., Erickson C., Shaffer D., O'Connor P.A., Sitarz A., Correra A., Schonfeld I.S. Prediction of intellectual deficits in children with acute lymphoblastic leukemia. Journal of Developmental & Behavioral Pediatrics. 9:1988;122-128.
117. Tubergen D.G., Gilchrist G.S., Sather H.N., Coccia P., Novak L., O'Brien R., Waskerwitz M., Hammond D. Intrathecal methotrexate provides adequate central nervous system therapy in acute lymphoblastic leukemia patients with intermediate risk factors and an age less than ten years. Proceedings of the American Society of Clinical Oncology. 7:1988;688.
118. Twaddle T., Britton P.G., Craft A.C., Noble T.C., Kernahan J. Intellectual function after treatment for leukemia or solid tumors. Archives of Diseases in Childhood. 58:1983;949-952.
119. Uberall M.A., Haupt K., Hertzberg H., Langer T., Meier W., Huk W.J., Beck J.D., Wenzel D. Quantitative EEG in long-term survivors of acute lymphoblastic leukemia. Pediatric Neurology. 15:1996;293-298.
120. Vainionpaa L. Clinical neurological findings of children with acute lymphoblastic leukaemia at diagnosis and during treatment. European Journal of Pediatrics. 152:1993;115-119.
121. Vainionpaa L., Kovala T., Tolonen U., Lanning M. Chemotherapy for acute lymphoblastic leukemia may cause subtle changes of the spinal cord detectable by somatosensory evoked potentials. Medical & Pediatric Oncology. 28:1997;41-47.
122. Waber D.P., Bernstein J.H., Kammerer B.L., Tarbell N.J., Sallan S.E. Neuropsychological diagnostic profiles of children who received CNS treatment for acute lymphoblastic leukemia. The systemic approach to assessment Developmental Neuropsychology. 8:1992;1-28.
123. Waber D.P., Isquith P.K., Kahn C.M., Romero I., Sallan S.E., Tarbell N.J. Metacognitive factors in the visuospatial skills of long-term survivors of acute lymphoblastic leukemia. An experimental approach to the Rey-Osterrieth Complex Figure Test Developmental Neuropsychology. 10:1994;349-367.
124. Waber D.P., Tarbell N.J. Toxicity of CNS prophylaxis for childhood leukemia. Oncology. 11:1997;259-265.
125. Waber D.P., Tarbell N.J., Fairclough D., Atmore K., Castor R., Isquith P., Lussier F., Romero I., Carpenter P.J., Schiller M., Sallan S.E. Cognitive sequelae of treatment in childhood acute lymphoblastic leukemia. Cranial radiation requires and accomplice Journal of Clinical Oncology, 13. 2490-2496:1995.
126. Waber D.P., Tarbell N.J., Kahn C.M., Gelber R.D., Sallan S.E. The relationship of sex and treatment modality to neuropsychologic outcome in childhood acute lymphoblastic leukemia. Journal of Clinical Oncology. 10:1992;810-817.
127. Walker R.W., Allen J.C., Rosen G., Caparros B. Transient cerebral dysfunction secondary to high-dose methotrexate. Journal of Clinical Oncology. 4:1986;1845-1850.
128. Whitt J.K., Wells R.J., Lauria M.M., Wilhelm C.L., McMillan C.W. Cranial radiation in childhood acute lymphocytic leukemia. American Journal of Diseases of Children. 138:1984;730-736.
129. Williams J.M., Davis K.S. Central nervous system prophylactic treatment for childhood leukemia. Neuropsychological outcome studies Cancer Treatment Reviews. 13:1986;113-127.
130. Williams J.M., Ochs J., Davis K.S., Daniel M. The subacute effects of CNS prophylaxis for acute lymphoblastic leukemia on neuropsychological performance. A comparison of four protocols Archives of Clinical Neuropsychology. 1:1986;183-192.
131. Williams K.S., Ochs J., Williams J.M., Mulhern R.K. Parental report of everyday cognitive abilities among children treated for acute lymphoblastic leukemia. Journal of Pediatric Psychology. 16:1991;13-26.
132. Wilson D.A., Nitschke R., Bowman M.E., Chaffin M.J., Sexauer C.L., Prince J.R. Transient white matter changes on MR images in children undergoing chemotherapy for acute lymphocytic leukemia. Correlation with neuropsychologic deficiencies Radiology. 180:1991;205-209.
133. Wizniter M., Packer R., Rorke L.B., Meadows A.T. Cerebellar sclerosis in pediatric cancer patients. Journal of Neuro-Oncology. 4:1987;353-360.